Blind spots in biodefense.
Science
; 379(6633): 621, 2023 02 17.
Article
in English
| MEDLINE | ID: covidwho-2269175
ABSTRACT
In October, the Biden administration released its National Biodefense Strategy (NBS-22), the first update since the COVID-19 pandemic began. Although the document notes that one of the lessons of the pandemic is that threats originating anywhere are threats everywhere, it frames threats as largely external to the United States. NBS-22 focuses primarily on bioterrorism and laboratory accidents, neglecting threats posed by routine practices of animal use and production inside the United States. NBS-22 references zoonotic disease but assures readers that no new legal authorities or institutional innovations are needed. Although the US is not alone in failing to confront these risks, its failure to comprehensively address them echoes across the globe.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Zoonoses
/
Bioterrorism
/
Biohazard Release
/
Biosecurity
Type of study:
Prognostic study
Limits:
Animals
/
Humans
Country/Region as subject:
North America
Language:
English
Journal:
Science
Year:
2023
Document Type:
Article
Affiliation country:
Science.adg9237
Similar
MEDLINE
...
LILACS
LIS